Information for Health Care Professionals

Medication Guide for patients

Medication Guide for patients

  • Includes Important Product Information for PRISTIQ

Get Adobe Reader

This document is in PDF (portable document format). PDF files require Adobe® Reader®; click here.

PRISTIQ Important Safety Information

PRISTIQ® (desvenlafaxine) is approved for the treatment of major depressive disorder in adults.

Suicidality and Antidepressant Drugs

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. PRISTIQ is not approved for use in children under 18.